Adalimumab
Stock Recap #PipelineProspector

Pipeline Prospector 2023 highlights: Obesity drugs perk up Lilly, Novo sales; ADCs spur dealmaking

The year 2023 was marked by volatility. The good news is that despite factors like inflation, intere

Pipeline Prospector Oct 2023: Disappointing Q3 results, attacks on Israel, Gaza drag pharma indices down further

October was a gloomy month that saw Palestinian militant group Hamas attack Israel in the first week

Pipeline Prospector March 2023: Silicon Valley Bank collapse hits biotech indices; Pfizer buys out Seagen

Biotech indices have witnessed a lot of volatility throughout 2022 and 2023. Just when they were beg